Uppsala Monitoring Centre
Birgitta Grundmark is a Medical Doctor and Researcher who has extensive experience in pharmacovigilance, signal detection, and oncology. Birgitta has held various positions at companies such as Uppsala Monitoring Centre, European Medicines Agency, and WHO-UMC network, focusing on assessing and validating safety signals of adverse drug reactions. With a background in oncology and clinical pharmacology, Birgitta has made significant contributions to the field of drug development and patient safety. Birgitta holds a Medical degree from Uppsala University and has a strong educational background in natural sciences.
This person is not in any offices
Uppsala Monitoring Centre
Uppsala Monitoring Centre is an independent, non-profit foundation and a centre for international service and scientific research in the field of pharmacovigilance. We advance the safety of patients by exploring and understanding the risks and benefits of medicines, with the ultimate aim of helping patients and physicians make wise therapeutic decisions. For more than 40 years, we have provided scientific leadership and operational support to the WHO Programme for International Drug Monitoring, expanding the global pharmacovigilance network to reach more than 95% of the world’s population. We create partnerships that bring together resources, expertise, and a shared vision of patient safety. Today, we continue to build a global drug safety culture by supporting and engaging all pharmacovigilance stakeholders, from national centres to regulators, academia and the pharma industry.